Variability of core microbiota in newly diagnosed treatment-naïve paediatric inflammatory bowel disease patients

T. G. J. de Meij, E. F. J. de Groot, C. F. W. Peeters, N. K. H. de Boer, C. M. F. Kneepkens, A. Eck, M. A. Benninga, P. H. M. Savelkoul, A. A. van Bodegraven, A. E. Budding

Research output: Contribution to journalArticleAcademicpeer-review

42 Citations (Scopus)


Background & aims Intestinal microbiota is considered to play a crucial role in the aetiology of inflammatory bowel disease (IBD). We aimed to describe faecal microbiota composition and dynamics in a large cohort of children with de novo (naïve) IBD, in comparison to healthy paediatric controls (HC). Methods In this prospective study, performed at two tertiary centres, faecal samples from newly diagnosed, treatment-naïve paediatric IBD patients were collected prior to bowel cleansing for colonoscopy (t0) and 1, 3 and 6 weeks and 3 months after initiation of therapy. The microbial profiles of Crohn’s disease (CD) and Ulcerative colitis (UC) patients were compared with HC and linked to therapeutic response. Microbiota composition was analysed by IS-pro technology. Results Microbial profiles of 104 new IBD-patients (63 CD, 41 UC, median age 14.0 years) were compared to 61 HC (median 7.8 years). IBD was mainly characterised by decreased abundance of Alistipes finegoldii and Alistipes putredinis, which characterize a healthy state microbial core. The classifier including these core species as predictors achieved an AUC of the ROC curve of .87. Core bacteria tended to regain abundance during treatment, but did not reach healthy levels.
Original languageEnglish
Article numbere0197649
Pages (from-to)e0197649
Issue number8
Publication statusPublished - 2018

Cite this